Mycology lab safety

From IDWiki
Revision as of 11:47, 16 August 2019 by Aidan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Biosafety levels

  • Biosafety risk groups
    • RG1: low individual risk and low community risk; e.g. Saccharomyces, Lactobacillus
      • Essentially non-pathogenic microbes
    • RG2: moderate individual risk and low community risk; e.g. Listeria, Campylobacter
    • RG3: high individual risk and low community risk; e.g. TB, Yersinia pestis, SARS
    • RG4: high individual risk and high community risk; e.g. Marburg virus, Ebola virus
  • Containment levels essentially correspond to the risk groups
    • CL1 through CL4
    • CL2-Ag for agriculture
    • CL2-P for prion
  • HRLMP has a CL2 microbiology lab at HGH.
  • Mycology laboratory
    • Class II B2 BSCs to eliminate puff-back during failure of ventilation. Ducts 100% HEPA-filtered air to the outside (no exhaust back into the laboratory). Toxic, volatile or radioactive chemicals can be used in this cabinet.
    • Examine all culture media in a BSC. All work/subculture must always be done in the BSC.
    • Seal all plates with Parafilm for: systemic specimens (respiratory, blood, tissue, body fluid).
    • Place all discarded plates into a tied up biological hazard bag before placing in discard bin.

Risk Group 3 fungi

  • Risk Group 3 fungi:
    • Blastomyces dermatitidis
    • Cladophialophora spp. including Clado. Bantiana (black mold that causes CNS disease)
    • Coccidioides immitis and Cocci. posadasii
    • Cryptococcus spp. including Crypto. gattii
    • Histoplasma spp. including H. capsulatum var. capsulatum, H. capsulatum var. farciminosum, and H. duboisii
    • Loboa loboi
    • Paracoccidioides brasiliensis
    • Rhinocladiella mackenziei (common cause of human cerebral phaeohyphomycosis)
  • Additional RG3 precautions:
    • Sealed windows
    • Use of a BSC for all work with open vessels
    • Inward-directional airflow
    • HEPA filtration of exhaust air
    • Strictly controlled lab access
  • CL2 laboratory management of RG3 organisms:
    • Perform all procedures with an organism that could be RG-3 in a BSC
      • Including all fungal culture media. Only open plates (including bacterial plates) that have a white or grey mold inside the Mycology BSC.
      • If KOH prep suggests dimorphic fungus:
        • Use lab gowns with elasticized wrists, gloves, and an N95 mask while examining plates in the BSC.
        • Place a warning note in LIS.
        • Notify the Manager/Supervisor and Microbiologist if plates grow white mold.
    • Notify the Microbiologist and Supervisor if suspect dimorphic fungi based on KOH-Calcofluor or plate growth.
    • All specimens are referred to the Toronto Public Health Lab following Transportation of Dangerous Goods regulations.
      • Follow all patient samples that went to other lab benches.

Laboratory-associated Coccidioides exposure

Risk assessment

  • There is a broad range of risk, and it may be difficult to assess. A small dose of arthroconidia may cause disease in humans, and attack rates in lab exposure are generally higher than natural exposure.
  • Risk increases with the quantity of arthroconidia and the duration of exposure.
  • Arthroconidia in culture develop after a few days, and reach very large numbers by 7 to 10 days, at which point they may be dispersed by simply opening the plate.

Managing exposed personnel

  • Obtain baseline Coccidioides serology for IgM and IgG to help determine prior exposure. Travel history may also be helpful.
  • All exposed personnel should be given itraconazole or fluconazole orally (400 mg daily, for adults) for 6 weeks, as prophylaxis.
    • If pregnant, avoid azoles, monitor closely, and start amphotericin if she develops infection. Can alternatively prophylax with once-weekly amphotericin for 6 weeks or until the end of pregnancy.
  • If any exposed personnel develops cough or fever during the 6 week period of prophylaxis, they should be assessed by a physician. Repeat serology may be helpful.
  • Repeat serology before completion of prophylaxis. If negative, stop prophylaxis; if positive, follow-up closely for up to 1 year.